Carr MJ, Sun J, DePalo D, Rothermel LD, et al. Talimogene Laherparepvec (T-VEC) for the Treatment of Advanced Locoregional Melanoma After Failure of Immunotherapy: An International Multi-Institutional Experience. Ann Surg Oncol 2021 Oct 14. pii: 10.1245/s10434-021-10910.
PMID: 34648098